 HYDERABAD, India--BUSINESS WIRE--Dr. Reddys Laboratories Ltd. BSE: 500124, NSE: DRREDDY, NYSE: RDY, announced its partnership with Biotechnology Industry Research Assistance Council BIRAC, Department of Biotechnology DBT, Government of India, for advisory support on clinical trials of Sputnik V vaccine in India. The partnership will allow Dr. Reddys to identify and use some of BIRACs clinical trial centres for the vaccine, which are funded under the National Biopharma Mission NBM, 